While Pfizer said in its petition for mass tort designation that it expected many of the dismissed plaintiffs to refile their claims, that prediction has not come to fruition. Now, there appears to be only a single Depo-Provera lawsuit pending in the Philadelphia Court of Common Pleas.
While Pfizer said in its petition for mass tort designation that it expected many of the dismissed plaintiffs to refile their claims, that prediction has not come to fruition. Now, there appears to be only a single Depo-Provera lawsuit pending in the Philadelphia Court of Common Pleas.
